Want to see SE:ISOFOL full AI Analyst Report?
Total Valuation
Isofol Medical AB has a market cap or net worth of kr245.18M. The enterprise value is kr160.59M.
Market Capkr245.18M
Enterprise Valuekr160.59M
Share Statistics
Isofol Medical AB has 320,491,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding320,491,640
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Isofol Medical AB’s return on equity (ROE) is -0.50 and return on invested capital (ROIC) is -50.48%.
Return on Equity (ROE)-0.50
Return on Assets (ROA)-0.42
Return on Invested Capital (ROIC)-50.48%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee0.00
Profits Per Employee-10.83M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Isofol Medical AB is ―. Isofol Medical AB’s PEG ratio is 0.39.
PE Ratio―
PS Ratio0.00
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-3.04
Price to Operating Cash Flow-4.14
PEG Ratio0.39
Income Statement
In the last 12 months, Isofol Medical AB had revenue of 0.00 and earned -54.17M in profits. Earnings per share was -0.25.
Revenue0.00
Gross Profit0.00
Operating Income-54.76M
Pretax Income-54.17M
Net Income-54.17M
EBITDA-54.76M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was -51.94M and capital expenditures 51.94M, giving a free cash flow of 0.00 billion.
Operating Cash Flow-51.94M
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Isofol Medical AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-10.60%
50-Day Moving Average0.71
200-Day Moving Average0.70
Relative Strength Index (RSI)66.76
Average Volume (3m)501.89K
Important Dates
Isofol Medical AB upcoming earnings date is Aug 25, 2026, TBA (Confirmed).
Last Earnings DateMay 19, 2026
Next Earnings DateAug 25, 2026
Ex-Dividend Date―
Financial Position
Isofol Medical AB as a current ratio of 6.19, with Debt / Equity ratio of 0.00%
Current Ratio6.19
Quick Ratio6.19
Debt to Market Cap0.00
Net Debt to EBITDA0.77
Interest Coverage Ratio-54.76K
Taxes
In the past 12 months, Isofol Medical AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Isofol Medical AB EV to EBITDA ratio is -2.12, with an EV/FCF ratio of -2.23.
EV to Sales0.00
EV to EBITDA-2.12
EV to Free Cash Flow-2.23
EV to Operating Cash Flow-2.23
Balance Sheet
Isofol Medical AB has kr126.99M in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr126.99M billion.
Cash & Marketable Securitieskr126.99M
Total Debtkr0.00
Net Cashkr126.99M
Net Cash Per Sharekr0.40
Tangible Book Value Per Sharekr0.50
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Isofol Medical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast9.40%